N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl-Reference-Cited by-同舟云学术

N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl

Published:1987-02 Issue:2 Volume:90 Page:335-345
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Karoum Farouk

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1987.tb08963.x/fullpdf

Reference34 articles.

1. Implication of combined treatment with ‘Modopar’ and L-deprenyl in parkinson's disease: a long-term study;Birkmayer;Lancet,1977

2. The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain;Campbell;J. Neurochem.,1979

3. Deprenyl in parkinson's disease;Eisler;Neurology,1981

4. Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the ‘cheese effect’;Elsworth;Psychopharmacology,1978

5. Selective inhibitors of monoamine oxidase types A and B and their usefulness;Fowler;Drugs Future,1982

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of monoamine oxidase A promotes secretory differentiation in basal prostatic epithelial cells;Differentiation;2008-09

2. Clinical Pharmacology of MAO Inhibitors: Safety and Future;NeuroToxicology;2004-01

3. Metabolism of Monoamine Oxidase Inhibitors;Cellular and Molecular Neurobiology;1999-06

4. Metabolism of monoamine oxidase inhibitors;Cellular and Molecular Neurobiology;1999

5. Orphan neurones and amine excess: the functional neuropathology of Parkinsonism and neuropsychiatric disease;Brain Research Reviews;1998-07